Tonix Pharmaceuticals Holding (TNXP) Notes Payables (2013 - 2014)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Notes Payables came in at $280000.0 in Q2 2014, little changed quarter-over-quarter from $280000.0 in Q1 2014.
Tonix Pharmaceuticals Holding (TNXP) Notes Payables (2013 - 2014) Analysis & Trends
Tonix Pharmaceuticals Holding's Notes Payables history runs 2 years deep, the most recent figure standing at $280000.0 for Q2 2014.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $280000.0 in Q2 2014; TTM through Jun 2014 was $280000.0, a N/A change from a year earlier, with the FY2013 full-year figure at $280000.0, changed N/A from the prior year.
- Notes Payables steadied at $280000.0 in Q2 2014 per TNXP's latest filing, from $280000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $280000.0 in Q3 2013 and bottomed at $280000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 280,000.00 |
| Mar 31, 2014 | 280,000.00 |
| Dec 31, 2013 | 280,000.00 |
| Sep 30, 2013 | 280,000.00 |